Plasma fat metabolites and hunger.
In order to test the hypothesis that the fat metabolites are the blood-borne signals which suppress hunger during recovery from reversible obesity, experiments were designed to manipulate plasma fat metabolite levels directly. In order to elevate plasma glycerol levels, glycerol was infused intravenously into relatively unrestrained rats for 36 hours; this treatment greatly increased plasma glycerol levels but reduced voluntary food intake only slightly. Similar results were obtained when glycerol was mixed with powdered rat food. These results suggest that glycerol is not the "lipostatic hormone" although it may contribute to regulation. Similar experiments with a synthetic precursor of the ketone bodies (1,3 butanediol), suggest that the ketone bodies contribute to the decrease in food intake after reversible obesity, but cannot be a complete explanation. Dietary fat consumption raised plasma free fatty acid (FFA) levels to the range seen during recovery from reversible obesity, suggesting that plasma FFAs may be a blood-borne signal of fat utilization in both cases. Intralipid, a synthetic triglyceride emulsion designed for intravenous administration, also increased plasma FFA levels but suppressed food intake by less than predicted. However, Intralipid may tend to cause spuriously high plasma FFA readings for reasons which are discussed. These results suggest that plasma fat metabolites, especially FFAs, may be blood-borne signals which contribute to the voluntary dieting after reversible obesity.
D000818:Animals; D001835:Body Weight; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005990:Glycerol / Q000097:blood*; D006815:Hunger / Q000502:physiology*; D007657:Ketone Bodies / Q000097:blood*; D008066:Lipolysis; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains
D005230:Fatty Acids, Nonesterified; D007657:Ketone Bodies; D005990:Glycerol